Skip to main content

Press Releases
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
November 8, 2018
Ironwood Pharmaceuticals to Present at 27th Annual Credit Suisse Healthcare Conference
Download PDF format download (opens in new window)
November 6, 2018
Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update
Download PDF format download (opens in new window)
October 25, 2018
Ironwood Pharmaceuticals to Host Third Quarter 2018 Investor Update Call
Download PDF format download (opens in new window)
October 8, 2018
Ironwood Pharmaceuticals Presenting IW-3718 and Linaclotide Data at the American College of Gastroenterology 2018 Annual Scientific Meeting
Download PDF format download (opens in new window)
September 13, 2018
Ironwood Pharmaceuticals Announces FDA Fast Track Designation for Praliciguat for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
Download PDF format download (opens in new window)
August 28, 2018
Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Download PDF format download (opens in new window)
August 21, 2018
Approval of Linzess® Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
Download PDF format download (opens in new window)
August 6, 2018
Ironwood Pharmaceuticals Provides Second Quarter 2018 Investor Update
Download PDF format download (opens in new window)
July 23, 2018
Ironwood Pharmaceuticals to Host Second Quarter 2018 Investor Update Call
Download PDF format download (opens in new window)
July 16, 2018
Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Download PDF format download (opens in new window)
June 23, 2018
Ironwood Presents Praliciguat Phase IIa Study Data Showing Positive Impact on Metabolic and Cardiovascular Clinical Endpoints at the American Diabetes Association’s 78th Scientific Sessions
Download PDF format download (opens in new window)
June 21, 2018
Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
Download PDF format download (opens in new window)
June 20, 2018
Ironwood Pharmaceuticals to Highlight Clinical and Preclinical Data for Praliciguat at the American Diabetes Association’s 78th Scientific Sessions
Download PDF format download (opens in new window)
June 7, 2018
Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
Download PDF format download (opens in new window)
June 6, 2018
Ironwood Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
Download PDF format download (opens in new window)
June 5, 2018
Ironwood Pharmaceuticals Presents IW-3718 Data Showing Improvements in Heartburn and Regurgitation Symptoms in Patients with Persistent GERD at Digestive Disease Week® 2018
Download PDF format download (opens in new window)
May 31, 2018
Ironwood Pharmaceuticals Announces Results of 2018 Annual Meeting of Shareholders
Download PDF format download (opens in new window)
May 23, 2018
Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week® 2018
Download PDF format download (opens in new window)
May 14, 2018
Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
Download PDF format download (opens in new window)
May 9, 2018
Ironwood Pharmaceuticals Files Investor Presentation Highlighting Actions Taken Designed to Unlock Shareholder Value
Download PDF format download (opens in new window)
May 3, 2018
Ironwood and Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS® (linaclotide) Patent Litigation
Download PDF format download (opens in new window)
May 2, 2018
Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
Download PDF format download (opens in new window)
May 1, 2018
Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action
Download PDF format download (opens in new window)
May 1, 2018
Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business
Download PDF format download (opens in new window)
May 1, 2018
Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
Download PDF format download (opens in new window)
April 17, 2018
Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call
Download PDF format download (opens in new window)
April 9, 2018
Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital
Download PDF format download (opens in new window)
March 5, 2018
Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
Download PDF format download (opens in new window)
February 15, 2018
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update
Download PDF format download (opens in new window)
February 1, 2018
Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call
Download PDF format download (opens in new window)
January 16, 2018
Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS® (linaclotide) Patent Litigation
Download PDF format download (opens in new window)
January 2, 2018
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)